Loading...
Market
Which major company will first partner with Oxford/AstraZeneca for bubonic plague vaccine distribution by end of 2025?
2
Resolution / Starting Odds
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Official partnership announcements from Oxford/AstraZeneca or partnering companies
Story
Oxford/AstraZeneca Scientists Develop Bubonic Plague Vaccine for Black Death Amid UK Stockpile Concerns
Jan 4, 2025, 06:35 PM
Scientists from Oxford University and AstraZeneca are developing a vaccine for the bubonic plague, responding to concerns about a potential superbug strain of the Black Death. Military experts have advised the UK government to stockpile supplies of this new inoculation. The initiative follows the team's previous work on the Covid-19 vaccine, highlighting ongoing efforts to prepare for emerging infectious diseases.
View original story
Similar markets
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Moderna • 25%
Pfizer • 25%
Other • 25%
Johnson & Johnson • 25%
Yes • 50%
No • 50%
Sanofi • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Pfizer • 25%
Other • 25%
Moderna • 25%
GlaxoSmithKline • 25%
GlaxoSmithKline • 25%
Pfizer • 25%
AstraZeneca • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Johnson & Johnson • 25%
Other • 25%
Merck • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Pfizer • 25%
Novartis • 25%
Other • 25%
Roche • 25%